Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

For patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20% of patients and associated factors include younger age, prednisone treatment, ...

Factors associated with recurrence of pericarditis include younger age, prednisone treatment, active systemic lupus erythematosus, and time since initial episode.

Kiniksa shifts focus to cardiovascular indications, halts abiprubart in Sjögren's, ends its AstraZeneca deal, and advances ...

It has been five years since the World Health Organisation (WHO) declared COVID-19 a pandemic in March 2020 a decision that ...

Kiniksa Pharmaceuticals (KNSA) witnessed a jump in share price last session on above-average trading volume. The latest trend ...

Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on developing anti-inflammatory ...

Carly Pearce has made waves in country music with her singing and songwriting, and even earned a Grammy in 2023 for her song ...

We recently compiled a list of the 12 Best Small Cap Pharma Stocks to Buy Now. In this article, we are going to take a look ...

Topline data readouts from multiple Phase 2 studies expected throughout 2025VTX2735 in patients with recurrent pericarditis in H2VTX3232 in ...

Corticosteroid use may increase pericarditis recurrence in lupus patients, according to a study published Feb. 25 in JAMA Network Open. Researchers from Baltimore-based Johns Hopkins Medicine led ...

A new study of more than 2,900 patients provides evidence that it's likely best to use as little corticosteroid medicine as possible when treating people who have lupus pericarditis, a common heart ...